<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02905409</url>
  </required_header>
  <id_info>
    <org_study_id>ILMIMH-CHINA</org_study_id>
    <nct_id>NCT02905409</nct_id>
  </id_info>
  <brief_title>Study of Surgery in Patients With Idiopathic Macular Hole</brief_title>
  <official_title>A Randomized, Double-masked, Multicenter, Controlled Study of Effects of Internal Membrane Peeling Surgery in Patients With Idiopathic Macular Hole Measured by Optical Coherence Tomography.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of two different internal limiting
      membrane peeling with distinct diameters after macular hole surgery on anatomical closure
      grades.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to investigate two distinct diameter of internal limiting
      membrane peeling on anatomical outcomes of macular hole surgery with different preoperative
      idiopathic macular hole.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 31, 2016</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anatomical closure grades in OCT</measure>
    <time_frame>6 months</time_frame>
    <description>The anatomical outcomes were defined as good closure and poor closure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of anatomical closure grades in OCT</measure>
    <time_frame>1 month, 3 months, 6 months, 1 year</time_frame>
    <description>The anatomical outcomes were defined as good closure and poor closure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in BCVA (best corrected visual acuity).</measure>
    <time_frame>1 month, 3 months, 6 months, 1 year</time_frame>
    <description>BCVA were measured by ETDRS chart.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">228</enrollment>
  <condition>Idiopathic Macular Hole</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>4PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients were stratified according to the macular hole closure index(MHCI) measured by OCT into 3 subgroup (MHCI&lt;0.5, 0.5≤MHCI&lt;0.7, MHCI≥0.7 ). And then randomized into 2 different intervention groups. If randomized into 4PD (papillary diameter) group, patients were given 4PD diameter of ILM (internal limiting membrane) peeling in surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients were stratified according to the macular hole closure index(MHCI) measured by OCT into 3 subgroup (MHCI&lt;0.5, 0.5≤MHCI&lt;0.7, MHCI≥0.7 ). And then randomized into 2 different intervention groups. If randomized into 2PD (papillary diameter) group, patients were given 2PD diameter of ILM (internal limiting membrane) peeling in surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ILM peeling surgery</intervention_name>
    <description>4PD or 2PD diameter of ILM peeling in surgery was given to patients with IMH (idiopathic macular hole)</description>
    <arm_group_label>2PD diameter of ILM peeling in surgery</arm_group_label>
    <arm_group_label>4PD diameter of ILM peeling in surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with IMH

          -  patients signed the ICF

          -  patients with course of IMH less than 3 years

        Exclusion Criteria:

          -  patients with hyper myopia

          -  patients with traumatic macular hole

          -  accompanied or secondary of other fundus disease

          -  open or reopen after receiving MH surgery

          -  patients with retinal detachment

          -  received vitrectomy due to other diseases

          -  glaucoma cannot be controled by medication

          -  patients with other retinal or choroidal disease that may affect VA

          -  poor patients compliance

          -  poor condition that cannot undertake the surgery

          -  dioptric media opacities which make it difficult to exam fundus or measure on OCT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mingwei Zhao, M.D</last_name>
    <role>Study Director</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hong Dai, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wenbin Wei, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tongren Hospital of Capital Medical University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youxin Chen, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mingwei Zhao, M.D</last_name>
    <phone>13801057408</phone>
    <email>dr_mingweizhao@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>People's Hospital of Peking University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minwei Zhao, M.D</last_name>
      <phone>13801057408</phone>
      <email>dr_mingweizhao@163.com</email>
    </contact>
    <investigator>
      <last_name>Youxin Chen, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wenbin Wei, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hong Dai, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>September 2, 2016</study_first_submitted>
  <study_first_submitted_qc>September 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2016</study_first_posted>
  <last_update_submitted>December 26, 2019</last_update_submitted>
  <last_update_submitted_qc>December 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Mingwei Zhao</investigator_full_name>
    <investigator_title>Head of Opthalmology Department, Principal Investigator, Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Perforations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

